Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department

BACKGROUND: A dual antiplatelet regimen has been shown to reduce the risk of major adverse cardiovascular events after percutaneous coronary intervention. However, there is little information available on inhibition of platelet aggregation in patients with a prior coronary stent presenting with ches...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rakesh K, Erickson, Stephen W, Sharma, Rohit, Voelker, Donald J, Reddy, Hanumanth K, Dod, Harvinder, Marsh, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646472/
https://www.ncbi.nlm.nih.gov/pubmed/23662064
http://dx.doi.org/10.2147/VHRM.S43909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646472/
https://www.ncbi.nlm.nih.gov/pubmed/23662064
http://dx.doi.org/10.2147/VHRM.S43909

Ejemplares similares